DuPont Achieves 100% Renewable Electricity in EU Operations

28.05.25 15:01 Uhr

Werte in diesem Artikel
Aktien

61,53 EUR 0,24 EUR 0,39%

USD 0,00 USD 0,00%

Indizes

5.912,2 PKT 23,6 PKT 0,40%

DuPont de Nemours, Inc. (DD) announced the achievement of 100% grid electricity from renewable sources across the entire European Union (“EU”) operations. This was done by using Renewable Energy Certificates (RECs), strengthening its commitment to achieving sustainability goals. This marked a key milestone toward the company’s goal of attaining net-zero carbon emissions by 2050.The conversion of European Union manufacturing sites to 100% renewable electricity underlined DD’s core value of protecting the planet. The transition entailed the installation of on-site solar panels and the purchase of bundled and unbundled RECs in 13 of its manufacturing sites in the European Union.In 2021, DuPont became a member of RE100, an international environmental initiative by the Climate Group in collaboration with CDP, bringing companies dedicated to transitioning operational electricity usage to entirely renewable energy sources together. DD is dedicated to accomplishing decarbonization in its operations by 2050.DD stock has lost 13.2% over the past year compared with the industry’s 25.8% decline.Image Source: Zacks Investment ResearchOn the first-quarter earnings call, DuPont announced that it projects net sales of approximately $3.2 billion, operating EBITDA of around $815 million and adjusted earnings per share of about $1.05 for the second quarter. This outlook reflects a seasonal sequential increase in sales. The company also maintained its full-year 2025 guidance.DD’s Zacks Rank & Key PicksDD currently carries a Zacks Rank #3 (Hold).Some better-ranked stocks in the Basic Materials space are Akzo Nobel N.V. AKZOY, Newmont Corporation NEM and Balchem Corporation BCPC. While AKZOY and NEM currently sport a Zacks Rank #1 (Strong Buy) each, BCPC carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.64 per share, implying a 17.14% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once.The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $3.92 per share, indicating a 12.64% year-over-year rise.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed it in one, with an average surprise of 32.41%. NEM’s shares have gained 30.1% in the past year.The Zacks Consensus Estimate for BCPC’s 2025 earnings is pegged at $5.15 per share, indicating a rise of 31% from year-ago levels. The company’s earnings beat the consensus estimate in two of the trailing four quarters while missing the rest. Its shares have gained 13.6% in the past year.    Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report DuPont de Nemours, Inc. (DD): Free Stock Analysis Report Newmont Corporation (NEM): Free Stock Analysis Report Akzo Nobel NV (AKZOY): Free Stock Analysis Report Balchem Corporation (BCPC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: DuPont de Nemours und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf DuPont de Nemours

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf DuPont de Nemours

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu DuPont de Nemours

Wer­bung

Analysen zu DuPont de Nemours

DatumRatingAnalyst
04.10.2021DuPont de Nemours OverweightJP Morgan Chase & Co.
20.08.2019DowDuPont OutperformCowen and Company, LLC
25.06.2019DowDuPont NeutralMonness, Crespi, Hardt & Co.
10.06.2019DowDuPont OutperformCowen and Company, LLC
06.02.2019DowDuPont Market PerformCowen and Company, LLC
DatumRatingAnalyst
04.10.2021DuPont de Nemours OverweightJP Morgan Chase & Co.
20.08.2019DowDuPont OutperformCowen and Company, LLC
10.06.2019DowDuPont OutperformCowen and Company, LLC
12.10.2018DowDuPont buyDeutsche Bank AG
29.03.2018DowDuPont OutperformBMO Capital Markets
DatumRatingAnalyst
25.06.2019DowDuPont NeutralMonness, Crespi, Hardt & Co.
06.02.2019DowDuPont Market PerformCowen and Company, LLC
12.09.2017DowDuPont NeutralMonness, Crespi, Hardt & Co.
31.05.2017Dow Chemical Market PerformCowen and Company, LLC
26.04.2017DuPont (E I DuPont de Nemours and Sector PerformRBC Capital Markets
DatumRatingAnalyst
05.01.2009Dow Chemical verkaufenEuro am Sonntag
11.04.2007Dow Chemical verkaufenHamburger Sparkasse
03.02.2006Update Rohm and Haas Co.: ReduceUBS
07.07.2005Update Rohm and Haas Co.: SellLongbow

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für DuPont de Nemours nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen